OppenheimerFunds’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

OppenheimerFunds’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-584,989	Closed	-$31.3M	–	1787
2016 Q1	$31.3M	Buy	584,989 +14,159	+2%	+$1.05M	0.04%	430
2015 Q4	$64.5M	Buy	570,830 +70,830	+14%	+$7.8M	0.08%	275
2015 Q3	$58.9M	Hold	500,000	–	–	0.08%	295
2015 Q2	$38.7M	Sell	500,000 -100,000	-17%	-$6.56M	0.04%	409
2015 Q1	$34.7M	Hold	600,000	–	–	0.04%	451
2014 Q4	$19.4M	Hold	600,000	–	–	0.02%	593
2014 Q3	$14.7M	Buy	+600,000	New	+$12.2M	0.02%	653

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

OppenheimerFunds's ANAC Position: Q2 2016 in Review

OppenheimerFunds sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 584,989 shares — an estimated $31.3M sold.

OppenheimerFunds first reported a position in ANAC in Q3 2014 and held it in 7 quarters. The position peaked at $64.5M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

OppenheimerFunds reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
OppenheimerFunds sold 584,989 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $31.3M.
OppenheimerFunds first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2014 and held it in 7 quarters.
OppenheimerFunds's ANACOR PHARMACEUTICALS INC COM position peaked at $64.5M in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on OppenheimerFunds's 13F filing for Q2 2016, filed 11 Aug 2016.